{
    "clinical_study": {
        "@rank": "30087", 
        "arm_group": [
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Corn/soy oil placebo capsules that are similar in shape and color to the DHA capsules given over 10 weeks"
            }, 
            {
                "arm_group_label": "DHA Omega-3", 
                "arm_group_type": "Experimental", 
                "description": "Long-chain omega-3 fatty acid docosahexaenoic acid (DHA) at 1,200 mg/day, 600 mg twice daily for 10 weeks"
            }
        ], 
        "brief_summary": {
            "textblock": "The study hypothesis is that DHA is more effective than placebo in increasing brain\n      activation and reducing symptoms in psychostimulant-naive children with ADHD."
        }, 
        "brief_title": "Effect of Omega-3 Fatty Acid on Cortical Function in ADHD", 
        "completion_date": {
            "#text": "November 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Attention Deficit Disorder", 
        "condition_browse": {
            "mesh_term": "Attention Deficit Disorder with Hyperactivity"
        }, 
        "detailed_description": {
            "textblock": "This study aims to determine the effects of 10-week dietary supplementation with the\n      long-chain omega-3 fatty acid docosahexaenoic acid (DHA) or placebo on prefrontal cortical\n      structural and functional connectivity using several neuroimaging techniques: DTI (Diffusion\n      Tensor Imaging), 1H MRS(Proton Magnetic Resonance Spectroscopy), and fMRI (Functional\n      Magnetic Resonance Imaging) in psychostimulant-naive children with attention deficit\n      hyperactivity disorder (ADHD). It is postulated that DHA supplements will increase brain\n      activation and reduce ADHD symptomatology."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Provision of written informed consent/assent\n\n          -  Ages 8-12 years old\n\n          -  Male gender\n\n          -  Meets DSM-IV-TR criteria for ADHD (combined type) as determined by the KSADS\n\n          -  Right handed determined by the Crovitz Handedness Questionnaire\n\n        Exclusion Criteria:\n\n          -  Contraindication to an MRI scan (i.e., braces, claustrophobia)\n\n          -  A history of a major medical (e.g., diabetes) or neurological illness (e.g.,\n             epilepsy)\n\n          -  Previous exposure to stimulant medications\n\n          -  Greater than 1 year outside appropriate age/grade level\n\n          -  A history of intolerance or hypersensitivity to omega-3 fatty acids\n\n          -  Currently taking omega-3 supplements\n\n          -  Not proficient in English language\n\n          -  Any history of a hematological disorder or concomitant use of anticoagulant\n             medications\n\n          -  Personal history of an Axis I psychiatric disorder other than ADHD"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "No", 
            "maximum_age": "12 Years", 
            "minimum_age": "8 Years"
        }, 
        "enrollment": {
            "#text": "30", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "June 6, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01883817", 
            "org_study_id": "2013-0199"
        }, 
        "intervention": [
            {
                "arm_group_label": "DHA Omega-3", 
                "description": "Patients will receive a fixed dose of DHA (1,200 mg/day, 600 mg twice daily) or placebo (corn/soy oil) over 10 weeks", 
                "intervention_name": "DHA Omega-3", 
                "intervention_type": "Drug", 
                "other_name": [
                    "Docosahexaenoic acid", 
                    "Omega 3 Fatty Acids"
                ]
            }, 
            {
                "arm_group_label": "Placebo", 
                "description": "corn/soy oil capsule with similar color, taste, and shape as experimental drug (DHA)", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug", 
                "other_name": "Inactive drug"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": "ADHD", 
        "lastchanged_date": "May 6, 2014", 
        "location": {
            "contact": {
                "email": "robert.mcnamara@uc.edu", 
                "last_name": "Robert K McNamara, PhD", 
                "phone": "513-558-5601"
            }, 
            "facility": {
                "address": {
                    "city": "Cincinnati", 
                    "country": "United States", 
                    "state": "Ohio", 
                    "zip": "45219"
                }, 
                "name": "University of Cincinnati, Department of Psychiatry and Behavioral Neuroscience"
            }, 
            "investigator": {
                "last_name": "Robert K McNamara, PhD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Docosahexaenoic Acid Augmentation of Cortical Attention Networks in ADHD", 
        "overall_contact": {
            "email": "dieckmdn@ucmail.uc.edu", 
            "last_name": "Deanna Dieckmann, BA", 
            "phone": "513-558-5059"
        }, 
        "overall_contact_backup": {
            "email": "dianna.moeller@uc.ed", 
            "last_name": "Dianna N Moeller, BA", 
            "phone": "513-558-2989"
        }, 
        "overall_official": {
            "affiliation": "University of Cincinnati", 
            "last_name": "Robert K McNamara, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "September 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Clinical improvement as measured by the ADHD Rating Scale", 
            "measure": "ADHD Symptoms", 
            "safety_issue": "No", 
            "time_frame": "10 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01883817"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Cincinnati", 
            "investigator_full_name": "Robert McNamara", 
            "investigator_title": "Associate Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Prefrontal cortical structural and functional connectivity measures", 
            "measure": "Cortical Functional Integrity", 
            "safety_issue": "No", 
            "time_frame": "10 weeks"
        }, 
        "source": "University of Cincinnati", 
        "sponsors": {
            "collaborator": {
                "agency": "DSM Nutritional Products, Inc.", 
                "agency_class": "Industry"
            }, 
            "lead_sponsor": {
                "agency": "University of Cincinnati", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}